South Carolina Dangerous Drug Lawyer

Byetta® and Januvia® are both used to help control blood sugar levels in Type 2 diabetes patients. Patients using the medications are reportedly at higher risk of developing pancreatitis and pancreatic cancer. Pancreatitis is a dangerous condition in its own right, but chronic pancreatitis might also lead to pancreatic cancer, which has a high fatality rate.

South Carolina Byetta® Attorney

Byetta®, known generically as Exenatide, is an injectable medication manufactured by Amylin Pharmaceuticals. A 2011 study published in Gastroenterology magazine found that patients using the drug were six times more likely to develop pancreatitis than those who treated with different dugs. Other facts regarding the dangers of Byetta® include the following:

  • The Food & Drug Administration (FDA) issued a warning to doctors and patients in 2007, just 2 years after Byetta®’s release, that the drug could be linked to high rates of pancreatitis and pancreatic cancer.
  • In 2009, the FDA required Amylin Pharmaceuticals to begin conducting studies dealing specifically with pancreatitis to determine if the benefits of the drug – suspected of increasing risk for pancreatitis, pancreatic cancer and thyroid cancer – outweighed the dangers.
  • A 2011 University of California, Los Angeles (UCLA) study revealed that diabetics using Byetta® were 6 times more likely to develop pancreatitis than those treated with other diabetes drugs. The drug also resulted in 2.9 times as many instances of pancreatic cancer than reported with other diabetes treatments.

Januvia® Lawyer in South Carolina

Januvia®, known generically as Sitagliptin and also marketed as Janumet®, is manufactured by Merck & Co. The FDA alerted doctors and patients in 2009 that the drug likely increased risk of pancreatitis. There were 88 reported cases of Januvia® patients developing pancreatitis between 2006 and 2009.

While Januvia® is an oral medication and Byetta® is an injectable, Januvia® has similar statistics in relation to pancreatitis and pancreatic cancer. UCLA researchers studied both drugs in 2011 and found that patients using Januvia® were also 6 times more likely to develop pancreatitis, and 2.7 times as likely as patients using different diabetes drugs to report pancreatic cancer.

Were you injured? Call us today for a free case review!

The South Carolina drug injury and mass torts attorneys at George Sink, P.A. Injury Lawyers willing to review potential Byetta® and Januvia® pancreatitis and pancreatic cancer cases. There is national litigation that South Carolina Byetta® and Januvia® victims can participate in. If you or a loved one developed pancreatitis, pancreatic cancer, or other health issues after using Byetta® or Januvia® to treat diabetes, contact the South Carolina personal injury attorneys at George Sink, P.A. Injury Lawyers.